Deloitte Advises Salix on its Sale
Deloitte Corporate Finance acted as exclusive financial advisor to Salix Animal Health and its related manufacturing entities on their joint sale to Spectrum Brands Holdings.
Conveying simultaneously with the sale of Salix are multiple Latin American manufacturing entities and a Netherlands-based distributor of Salix products. The Company’s related Latin American factories are located in Mexico, Ecuador, Colombia, and Brazil. Salix’s flexible supply chain gives Spectrum’s pet business increased optionality for a low-cost global rawhide production network.
“Deloitte Corporate Finance’s deep transaction and industry experience added value throughout the sale process. DCF’s consumer sector knowledge was vital to our selection of Spectrum as our partner. Salix customers will benefit from Spectrum’s world-class innovation, global sourcing capabilities, and marketing expertise. With synergistic manufacturing operations and a shared devotion to quality and safety, we see a bright future for the combined business,” said Marc Kreamer, founder of Salix Animal Health.
“The Salix management team has worked tirelessly to build a company devoted to providing pet owners with safe, high-quality chews and treats for their canine companions. DCF’s cross-border and consumer sector experience enabled us to identify an acquiror with a shared vision of growth and a focus on quality and safety. This deal marks DCF’s second in the pet space in the past 60 days, further emphasizing the consumer trend towards increased spending on companion pets,” said Lorin DeMordaunt, managing director and Consumer and Retail group lead, Deloitte Corporate Finance LLC.
Deerfield Beach, FL-headquartered Salix is a producer and distributor of premium, natural rawhide dog chews, treats and snacks.